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the fungal cell wall. The caspofungin-mediated disruption 
of glucan synthesis leads to the formation of an osmoti-
cally fragile aberrant cell wall and osmotic lysis of the 
cell at high concentrations [1]. Caspofungin contains 
a long fatty acid side chain that may allow intercalation 
in the bi-layer of the fungal cell membrane [5] where 
it may interact with, and disrupt the function of, the 
 β -1,3-D-glucan synthase. 
 Aspergillus fumigatus is an important fungal pathogen, 
particularly affecting those with pre-existing pulmonary 
malfunction (e.g., asthma, cystic fi brosis), disease (e.g., 
cancer, tuberculosis, chronic granulomatous disease), 
or undergoing immunosuppressive therapy prior to 
organ transplantation [6]. The fungus can induce a 
variety of diseases including allergic and invasive aspergil-
losis [7]. The latter is the most serious form of disease 
as it involves the invasion of viable tissue and may 
produce a mortality rate in excess of 80% [8,9]. Treatment 
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 Caspofungin is a member of the echinocandin class of antifungal agents that inhibit 
the synthesis of  β 1,3 glucan thus disrupting fungal cell wall structure and function. 
Exposure of the  Aspergillus fumigatus cultures to caspofungin (0.01, 0.1 or 1.0  μ g/ml) 
resulted in a reduction in cell growth, but the production of the epipolythiodioxopipera-
zine toxin, gliotoxin, was comparable, or greater, in cultures exposed to caspofungin 
than untreated controls. Exposure of  A. fumigatus hyphae to 1.0  μ g/ml caspofungin for 
4 h resulted in the release of amino acids ( P    0.01), protein ( P    0.002) and gliotoxin 
( P    0.02). Cultures of  A. fumigatus incubated in the presence of caspofungin for 4 or 
24 h demonstrated enhanced gliotoxin release ( P    0.04 and 0.03, respectively) and bio-
synthesis ( P    0.04 and 0.03, respectively) compared to that by control cultures. The 
results presented here indicate that exposure of  A. fumigatus to caspofungin results in 
increased cell permeability and an increase in the synthesis and release of gliotoxin. 
Since gliotoxin has well established immunosuppressive properties it is possible that 
exposure of  A. fumigatus to caspofungin may potentiate the production of this toxin at 
the site of infection. Elevated gliotoxin biosynthesis may be an attempt by the fungus to 
restore the redox balance of the cell following exposure to the antifungal agent but the 
overall effect appears to be enhanced synthesis and release. 
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 Introduction 
 Caspofungin was the fi rst member of the echinocandins to 
be licensed for use [1] and shows excellent  in vitro and  in 
vivo activity against  Candida and  Aspergillus species 
[2,3]. Caspofungin has an excellent safety profi le and it is 
as effective as, and usually better tolerated than, liposomal 
amphotericin B [4]. Unlike polyenes and azoles (that 
target ergosterol or the ergosterol biosynthetic pathway, 
respectively) echinocandins function by inhibiting the 
synthesis of  β -1,3-D-glucan, an essential component of 
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can be diffi cult due to late diagnosis of disease and therapy 
with amphotericin B can induce a variety of negative side-
effects [8]. 
 A. fumigatus displays a number of virulence factors that 
may facilitate tissue colonization and persistence in the 
host [10 – 12]. One of these, gliotoxin (C 13 H 14 N 2 O 4 S 2 , 
molecular weight 326.4), is an epipolythiodioxopiperazine 
toxin [13] which displays immunosuppressive properties 
 in vivo [14]. Gliotoxin is capable of inhibiting macrophage 
function and may alter the immune response to  Aspergillus 
as it can induce apoptotic cell death in macrophages 
[13,15], and disrupt the function of neutrophils [16]. 
Gliotoxin has been detected in humans where it may facil-
itate fungal persistence and colonization of tissue [17,18]. 
In addition, gliotoxin has been implicated in the destruc-
tion of lung parenchyma in invasive aspergillosis [15] 
and the penetration of blood vessels in angio-invasive 
aspergillosis [19]. 
 We previously established that exposure of  A. fumiga-
tus to the polyene antifungal amphotericin B leads to 
membrane leakage, as measured by the release of amino 
acids and protein, and of the immunosuppressive toxin, 
gliotoxin [20]. It was established that amphotericin B 
induced the leakage and  de novo biosynthesis of gliotoxin 
 – a feature that could have signifi cant implications for 
patients receiving amphotericin B therapy. Caspofungin 
has previously been shown to induce amino acid and pro-
tein leakage from growth-arrested stationary phase  Can-
dida albicans cells indicating that inhibition of glucan 
biosynthesis may not be the only mode of action exhibited 
by this drug [21]. It was postulated that caspofungin could 
have a secondary effect in altering membrane permeabil-
ity. The aim of the work presented here was to establish 
if exposure of  A. fumigatus to caspofungin induced leak-
age of gliotoxin and whether the fungus responded to this 
by synthesizing elevated levels of toxin intra-cellularly. 
The immunosuppressive effects of gliotoxin are well 
established [14 – 16] and any therapy that inadvertently 
induced the increased biosynthesis and release of this 
toxin could exacerbate infl ammation and tissue damage at 
the site of infection. 
 Materials and methods 
 Aspergillus fumigatus culture conditions 
 Aspergillus fumigatus ATCC 26933 (obtained from the 
American Type Culture Collection, Maryland, USA) was 
used in this study.  Aspergillus cultures were grown in 
RPMI1640 (GIBCO) medium supplemented with 5% (v/v) 
fetal calf serum (FCS, Sigma Aldrich) at 37 ° C and 200 
rpm, for up to 4 days.  A. fumigatus was maintained on malt 
extract agar (MEA) plates (Oxoid Ltd). 
 Preparation of caspofungin 
 Caspofungin (Cancidas, Merck  & Co., Inc.) was dissolved 
in sterile water to give a stock concentration of 1,000  μ g/
ml prior to diluting in sterile water to working concentra-
tions. Stock solutions were stored in 50  μ l aliquots 
at   80 ° C. 
 Effect of caspofungin on growth of A. fumigatus 
 MEA plates containing sporulating  Aspergillus colonies 
were washed with 10 ml of 0.01% (v/v) Tween 80 (Merck) 
in Phosphate Buffered Saline (PBS, pH 7.2; Sigma Aldrich) 
to isolate conidia. The latter were washed twice in sterile 
PBS, harvested by centrifugation (1,500  g , 5 min in a 
Beckman GS-6 centrifuge) and enumerated using an 
haemocytometer. Sterile fl asks containing RPMI (50 ml) 
were inoculated with  Aspergillus conidia to give a concen-
tration of 1   10 5 /ml and incubated at 37 ° C and 200 rpm. 
Cultures were supplemented with caspofungin (0.01, 0.1 
or 1.0  μ g/ml) at various times. It was previously deter-
mined that a concentration of 0.1  μ g/ml caspofungin inhib-
ited growth of  A. fumigatus by approximately 50% (data 
not provided). Flasks were removed at each time point and 
the contents fi ltered through Whatman No. 1 fi lters in a 
B ü chner funnel. A growth curve was constructed of fungal 
biomass versus incubation time. 
 Evaluation of amino acid and protein leakage from 
A. fumigatus exposed to caspofungin 
 Aspergillus fumigatus conidia were inoculated into 50 ml 
of RPMI to give a fi nal concentration of 1   10 5 conidia/
ml and incubated at 37 ° C for 96 h. Hyphae were collected 
by fi ltering through miracloth (Calbiochem) and washed 
twice with 10 ml sterile PBS. The hyphal mass (2 g) was 
re-suspended in 25 ml PBS containing 0.5% v/v Dimethyl 
sulfoxide (DMSO) (as positive control), or caspofungin 
(0.1  μ g/ml or 1.0  μ g/ml) and the cultures were incubated 
at 37 ° C and 200 rpm for another 0.5, 2 or 4 h. At each time 
point 750  μ l of culture fi ltrate was removed and fi ltered 
through 0.45  μ M syringe fi lters (Sarstedt). Free amino 
acids were measured using the ninhydrin colorimetric 
method [22] and expressed in terms of aspartic acid and 
glutamic acid, which were used as standards. To determine 
the quantity of protein released from the hyphal mass, 
samples were assayed using the Bradford assay (Bio-Rad), 
with BSA (Sigma Aldrich) as standard. 
 Extraction of gliotoxin from A. fumigatus culture fi ltrate 
 At each time point the culture contents were fi ltered through 
miracloth, weights were recorded and gliotoxin was 
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acetonitrile (Hyper Solv, BDH), 0.1% (v/v) trifl uoroacetic 
acid (Sigma Aldrich) and 65% (v/v) deionized-distilled 
water. Gliotoxin extract (10 ml) was injected onto a C18 
Hewlett Packard column. A standard curve of peak area 
versus gliotoxin concentration was constructed using glio-
toxin standards (0.1, 0.2, 0.5, 1.0  μ g/10  μ l) dissolved in 
methanol (Sigma Aldrich). 
 Statistical analysis 
 All assays were performed on three independent occasions. 
Results presented are the mean   standard deviation. Sta-
tistical analysis were performed using Student ’ s two-tailed 
 t -test with values of  P    0.05 considered statistically sig-
nifi cant and indicated with  * . 
 Results 
 Effect of caspofungin on growth and gliotoxin production by 
A. fumigatus 
 Cultures of  A. fumigatus were grown in RPMI 1640 
medium supplemented with 0.01, 0.1 or 1.0  μ g/ml caspo-
fungin for 96 h. The biomass and gliotoxin concentration 
( μ g/g hyphae) at different time points were determined. 
The results demonstrate that incubation of the fungus 
in the presence of caspofungin retarded hyphal growth 
(Fig. 1A). At 72 h, the control culture reached a hyphal 
extracted from the culture fi ltrate by mixing with an equal 
amount of chloroform (Sigma-Aldrich) for 2 h. The extrac-
tion of gliotoxin from the chloroform layer was accom-
plished by rotary evaporation at 55 ° C. The dried extracts 
were dissolved in 250  μ l of molecular-grade methanol 
(Sigma-Aldrich) and the level of gliotoxin determined by 
Reverse phase high performance liquid chromatography 
(RP-HPLC) [20]. 
 Extraction of gliotoxin from hyphae of A. fumigatus 
 Intracellular gliotoxin was extracted from the hyphae of 
 A. fumigatus by fi rst recovering hyphae from RPMI culture 
media by fi ltration. The hyphal mass was then washed twice 
in PBS and ground to a fi ne powder using a pestle and mor-
tar under liquid nitrogen. The crushed hyphal powders were 
re-suspended in 10 ml of 6 M HCl (Sigma-Aldrich). Chlo-
roform (35 ml) was added and the mixture was stirred at 
room temperature for 2 h. The chloroform layer was sepa-
rated and gliotoxin was extracted by evaporation of chloro-
form using a rotary evaporator at 55 ° C. The dried extracts 
were dissolved in 250  μ l of molecular-grade methanol and 
the level of gliotoxin determined using RP-HPLC. 
 Quantifi cation of gliotoxin by RP-HPLC 
 Gliotoxin was detected by Reversed Phase-HPLC 
(Spectra-Physics). The mobile phase was 34.9% (v/v) 
 Fig. 1 (A) and (B) Effect of caspofungin on growth and gliotoxin production by  Aspergillus fumigatus . Cultures of  A. fumigatus were grown in the 
presence of caspofungin (0.01, 0.1 or 1.0  μ g/ml) for 96 hours and fungal biomass (A) and gliotoxin production ( μ g/g hyphae) (B) was determined at 
24-hour intervals.  * P    0.01. 
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mass of 17.8 g/l, whereas the culture supplemented with 
0.01  μ g/ml caspofungin had achieved a mass of 13 g/l. 
Cultures supplemented with 0.1  μ g/ml caspofungin 
achieved a weight of 8.2 g/l at the same time point, while 
those cultures supplemented with caspofungin at a concen-
tration of 1.0  μ g/ml reached a hyphal mass of 5.8 g/l. 
 Analysis of the gliotoxin concentration in the culture 
medium revealed that peak levels were attained at 72 h and 
declined thereafter (Fig. 1B). The highest concentration of 
gliotoxin was found in the culture supplemented with 1.0 
 μ g/ml caspofungin (311.71  μ g/g of hyphae) at 72 h. The 
gliotoxin concentration of the control culture was 261.78 
 μ g/g hyphae at this time (Fig. 1B). It is clear from these 
results that while exposure to caspofungin inhibited fungal 
growth, the level of gliotoxin production, as a function of 
hyphal weight, was similar to, or greater than, that pro-
duced by the control. 
 Effect of caspofungin on release of amino acids and protein 
from A. fumigatus 
 Cultures of  A. fumigatus were grown at 37 ° C for 96 h, 
harvested, washed and resuspended in PBS supplemented 
with caspofungin (0.1 or 1.0  μ g/ml) or 0.5% DMSO, as 
the positive control due to its well known ability to solu-
bilize membranes. Cultures were incubated at 37 ° C for 
4 h and the release of amino acids and protein was 
quantifi ed as described above. Cultures exposed to 1.0  μ g/
ml caspofungin were found to have an elevated release of 
amino acids compared to negative and positive controls at 
2 and 4 h ( P    0.01; Fig. 2A). A similar trend was noted 
in protein release from the hyphae in caspofungin supple-
mented especially after 4 h exposure of hyphae to the drug 
where the greatest level of protein release was from the 
hyphae exposed to 1.0  μ g/ml caspofungin ( P    0.002; Fig. 
2B). These results demonstrate the increased leakage of 
amino acids and protein from  A. fumigatus hyphae when 
exposed to caspofungin. 
 Effect of caspofungin on release of gliotoxin from 
A. fumigatus 
 Cultures of  A. fumigatus were grown at 37 ° C for 96 h, 
harvested, washed and resuspended in PBS supplemented 
with caspofungin (0.1 or 1.0  μ g/ml) or 0.5% DMSO. The 
release of gliotoxin was quantifi ed by RP-HPLC after 4h 
exposure to the drug or DMSO. The results indicate that 
the culture supplemented with 1.0  μ g/ml caspofungin 
released a signifi cantly greater amount of gliotoxin 
(15.56    0.52  μ g/ml) than the untreated control (5.86    0.3 
 μ g/ml) ( P    0.02; Fig. 3). Gliotoxin leakage from DMSO 
treated cells was also evident (11.05    1.45  μ g/ml). Expo-
sure of stationary phase  A. fumigatus hyphae leads to 
increased leakage of gliotoxin. 
 Fig. 2 (A) and (B) Caspofungin exposure induces leakage of amino acids and protein from  Aspergillus fumigatus . The release of amino acid (A) and 
protein (B) from 96 h old cultures of  A. fumigatus following exposure of hyphae to two different concentrations of caspofungin for 4 hour in PBS was 
measured. Statistically signifi cant difference compared to control indicated by  * P    0.05. 
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 Short-term (4 h) exposure to caspofungin potentiates 
gliotoxin production and release by A. fumigatus 
 Cultures of  A. fumigatus were grown for 96 h in RPMI 
medium at 37 ° C. Cultures were supplemented with caspo-
fungin (0.01, 0.1 or 1.0  μ g/ml) for 4 h. After this time 
hyphae were harvested, washed, and resuspended in the 
same volume of fresh RPMI medium as previously. The 
concentration of gliotoxin in the culture medium and within 
the hyphae (intracellular) was assessed for up to 48 h after 
the short-term (4 h) exposure to caspofungin. Cultures 
exposed to 1.0  μ g/ml caspofungin had signifi cantly higher 
gliotoxin concentrations in the medium at 24 h (7.94    1.88 
 μ g/ml) and 48 h (11.19    0.57  μ g/ml) post-exposure to 
caspofungin compared to the relevant control ( P    0.04; 
Fig. 4A). 
 Internal concentrations of gliotoxin were also measured, 
as described, 48 h post-exposure to caspofungin (Fig. 4B). 
Internal gliotoxin levels were signifi cantly higher 
(224.8  μ g/g of hyphae) in the cultures that had been 
exposed to 1  μ g/ml caspofungin for 4 h compared to the 
control ( P    0.04). These results reveal that short-term 
(4 h) exposure to caspofungin has the ability to potentiate 
the production of gliotoxin when cells are placed in fresh 
medium. 
 Exposure of cultures of A. fumigatus to caspofungin for 24 
hours leads to increased internal and external concentrations 
of gliotoxin 
 Cultures of  A. fumigatus were grown in RPMI medium for 
96 h at 37 ° C at which time caspofungin was added to cul-
tures to give fi nal concentrations of 0.1 or 1.0  μ g/ml. The 
cultures were then incubated for a further 24 h in RPMI 
medium at which time the internal and external gliotoxin 
concentrations were ascertained as described. The results 
reveal an increase in the external gliotoxin concentration 
in cultures that were supplemented with caspofungin. The 
culture supplemented with 1.0  μ g/ml caspofungin had a 
signifi cantly higher level of gliotoxin in culture medium at 
8 h (8.29    0.08  μ g/ml), 16 h (6.09    0.5  μ g/ml) and 24 h 
(6.78    0.29  μ g/ml) (Fig. 5A) compared to the relevant 
controls ( P    0.03). In addition, the intracellular concentra-
tion of gliotoxin at 24 h also increased in the cultures 
 Fig. 4 Effect of short-term caspofungin exposure (4 hour) on gliotoxin release and biosynthesis in  Aspergillus fumigatus . Extracellular gliotoxin 
concentration (A) and internal concentration of gliotoxin (B) in  A. fumigatus 4, 24 and 48 hours after exposure of hyphae to caspofungin for 4 hours 
was measured. The intracellular concentration of gliotoxin was measured at 48 hours. Statistically signifi cant ( P    0.05) difference compared to control 
indicated by  * P    0.04.  * * indicates  P    0.023). 
 Fig. 3 Effect of caspofungin on release of gliotoxin from  Aspergillus fumigatus following 4 hour exposure to the drug. The level of gliotoxin released 
by  A. fumigatus after 4 h exposure to 0.1 or 1.0  μ g/ml caspofungin was measured.  * P    0.02. 
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supplemented with 0.1 or 1.0  μ g/ml caspofungin relative 
to the control ( P    0.03; Fig. 5B). These results indicate 
that incubation of stationary phase cultures of  A. fumigatus 
with caspofungin for 24 h leads to increased extracellular 
and intracellular levels of gliotoxin. 
 Discussion 
 Caspofungin is a highly effective antifungal agent with 
proven effi cacy against a wide range of fungal pathogens 
[2]. It is well tolerated  in vivo and no signifi cant instances 
of clinical resistance have been documented [2,23]. Its low 
toxicity makes it a more attractive agent for antifungal 
therapy than amphotericin B which has well characterized 
toxic side-effects. The results presented here demonstrate 
that exposure of  A. fumigatus to caspofungin results in 
increased membrane permeability as measured by the ele-
vated release of amino acids, protein and gliotoxin. In addi-
tion, there are greater levels of gliotoxin within cells that 
are exposed to caspofungin for a short (4 h) or long (24 h) 
period. Exposure of  A. fumigatus to caspofungin leads to 
enhanced internal and external gliotoxin concentrations up 
to 48 h after the beginning of the exposure period (Fig. 4A 
and 4B). Interestingly exposure of growing cultures of 
 A. fumigatus to caspofungin results in reduced biomass but 
the production of gliotoxin is comparable to that in control 
cultures (Fig. 1A and 1B). 
 While gliotoxin has well established cytotoxic proper-
ties [24], its primary function may be to act as an antioxi-
dant within the fungal cell and so protect it from the effects 
of exogenous and endogenous oxidants [25]. We have pre-
viously demonstrated the activation of the Cap and Hog 
pathways in  C. albicans when exposed to caspofungin 
indicating the drug induces oxidative and osmotic stress 
within the cells [26]. The increased level of gliotoxin 
within  A. fumigatus following exposure to caspofungin as 
evident by this study may be an attempt by the cell to 
restore the redox balance disrupted by exposure to caspo-
fungin, or by the loss of toxin from within the cell. While 
gliotoxin may represent a means by which  A. fumigatus 
regulates its environment, the net effect of increased bio-
synthesis and release following exposure to caspofungin is 
the possibility of enhanced tissue damage and infl amma-
tion at the site of infection. 
 We previously established that exposure of growth 
arrested stationary phase  C. albicans cell to caspofungin 
induced the release of amino acids and a variety of intrac-
ellular peptides [21]. Caspofungin inhibits glucan biosyn-
thesis which results in disruption of fungal cell wall 
synthesis and ultimately cell lysis when high concentra-
tions are employed [1]. In the results presented here, and 
in those of the earlier work [21], stationary phase cultures 
of  A. fumigatus or  C. albicans were exposed to caspo-
fungin so  de novo wall formation would not have been a 
signifi cant. Consequently, it is possible that in addition to 
inhibiting glucan biosynthesis, caspofungin may have a 
secondary effect on membrane permeability and thus facil-
itate the leakage of amino acids, protein and toxins from 
fungal cells. Depletion of the intracellular gliotoxin con-
centration may stimulate increased biosynthesis of the 
toxin to replenish the lost gliotoxin in order to restore the 
redox balance within the cell [25]. This phenomenon of 
caspofungin-induced gliotoxin leakage and  de novo bio-
synthesis has the potential to contribute to elevated levels 
of pulmonary damage and immunosuppression [16,24]. It 
is possible that administration of caspofungin to patients 
may lead to eventual fungal cell death but that before this 
is achieved internal gliotoxin would be released from cells 
and the cells could have the opportunity to commence syn-
thesizing more toxin to replenish that which is lost into 
surrounding tissue. Previous work that examined the 
response of  C. albicans to amphotericin B illustrated the 
ability of cells to recover from antifungal therapy even 
though they appeared incapable of replicating in culture 
 Fig. 5 Effect of long-term caspofungin exposure (24 hour) on gliotoxin release and biosynthesis in  Aspergillus fumigatus . Extracellular and intracellular 
gliotoxin levels in 96-hour-old cultures after exposure to caspofungin for 24 hours. Gliotoxin release was measured at 8, 16 and 24 hours after addition 
of caspofungin to cultures (A). The intracellular concentration of gliotoxin was measured at 24 hours (B). Statistically signifi cant difference compared 
to control indicated by  * P    0.03. 
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thus highlighting the possibility of continued cell survival 
in the presence of  ‘ fungicidal ’ concentrations of drug [27]. 
This fi nding illustrates the possibility of continued glio-
toxin biosynthesis in the presence of caspofungin concen-
trations that would inhibit fungal cell growth. 
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